Provided by Tiger Fintech (Singapore) Pte. Ltd.

Baxter

29.80
-0.1200-0.40%
Post-market: 29.800.00000.00%19:57 EDT
Volume:3.51M
Turnover:104.86M
Market Cap:15.29B
PE:-27.19
High:30.10
Open:29.87
Low:29.54
Close:29.92
Loading ...

Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX) and Baxter International (BAX)

TIPRANKS
·
02 May

Upcoming Aditxt Weekly Update to Feature Dr. Shahrokh Shabahang, Chief Innovation Officer (CIO) of Aditxt™, and Dr. Friedrich Kapp, Co-CEO of Adimune™, to Discuss Progress of Lead Therapeutic Candidate ADI-100™

Business Wire
·
02 May

Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS ...

GuruFocus.com
·
02 May

Baxter International Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
02 May

Balanced Outlook on Baxter International: Strong Performance with Margin Concerns

TIPRANKS
·
02 May

Evercore ISI Adjusts Baxter International Price Target to $44 From $45, Maintains Outperform Rating

MT Newswires Live
·
02 May

Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps

Benzinga
·
01 May

BUZZ-Baxter rises after strong medical device sales drives quarterly results beat

Reuters
·
01 May

Baxter Shares up 2.8% After Co Beats Q1 Revenue and Profit Estimates

THOMSON REUTERS
·
01 May

Baxter International Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks
·
01 May

Baxter International's Q1 Adjusted Net Income Drops, Revenue Rises; Full-Year 2025 Guidance Revised

MT Newswires Live
·
01 May

Baxter International Inc Surpasses Q1 2025 Estimates with $0.55 EPS and $2.63 Billion Revenue

GuruFocus
·
01 May

BRIEF-Baxter Q1 Adjusted EPS USD 0.62 Vs. IBES Estimate USD 0.48

Reuters
·
01 May

Baxter International Reports 5% Sales Increase and Adjusted EPS of $0.55 in Q1 2025, Exceeds Guidance

Reuters
·
01 May

Baxter Outlook FY25 Adj Earnings From Continuing Operations, Before Special Items, of $2.47 to $2.55 per Diluted Share

THOMSON REUTERS
·
01 May

Baxter Outlook FY Revenue Growth 7-8%

THOMSON REUTERS
·
01 May

Baxter: Q2 Outlook Sales Growth From Continuing Operations of 4% to 5% on a Reported Basis

THOMSON REUTERS
·
01 May

Baxter Q1 Revenue USD 2,625 Million VS. Ibes Estimate USD 2,587 Million

THOMSON REUTERS
·
01 May

MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK

Zacks
·
30 Apr